Amgen Gets CHMP's Positive Opinion To Extend Indication Of Kyprolis For Relapsed Multiple Myeloma Treatment

Amgen (NASDAQ: AMGN) revealed that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has ...